NewDirectContract MCPSet up MCP →

Provider intelligence

Waltz Health

DirectContract tracks 1 documented arrangement involving Waltz Health across counterparties including Self-insured employers (platform). The records span 1 market and include Transparent Pricing structures, with source-backed economics where publicly available.

1

Tracked contracts

—

Covered lives represented

1

Active or expanded

—

Highest reported savings

Tracked arrangements

Waltz Health ↔ Self-insured employers (platform)

United States · 2025-11

Waltz Health launched a direct-to-employer access model for GLP-1 obesity management medications in November 2025. The platform allows self-insured employers to offer tirzepatide and semaglutide at transparent, contracted prices without traditional PBM markup.

Model: Transparent Pricing

Status: active

Lives: Not disclosed

Savings: Lower net cost on obesity management drugs vs. traditional PBM

Primary source ↗